ImmunityBio, Inc. IBRX Accrued Marketing and Advertising Expenses
Accrued Marketing and Advertising Expenses at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedMarketingCostsCurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s accrued marketing and advertising expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s accrued marketing and advertising expenses?
- ImmunityBio, Inc. (IBRX) reported accrued marketing and advertising expenses of $8.07M in Q1 2026.
- How has ImmunityBio, Inc.'s accrued marketing and advertising expenses changed year-over-year?
- ImmunityBio, Inc.'s accrued marketing and advertising expenses increased by 271.8% year-over-year, from $2.17M to $8.07M.